Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better.

From the week of the 10th of February, we are planning to work on 14 projects, including:

Reimbursement

1. Delivering the reimbursement analysis for embolization procedures in different indications in England, France, Germany, Italy, and Spain
2. Delivering the reimbursement analysis for treatment of endoleak following endovascular treatment of aortic aneurysm in England, France, Germany, and Italy
3. Delivering the reimbursement analysis for ostomy products in France and Germany
4. Working on reimbursement analysis for several technologies in ophthalmological, urological, and oncological fields in Belgium and the Netherlands
5. Working on reimbursement analysis for orthopedic technology in Belgium, Italy, the Netherlands, and Spain
6. Working on the reimbursement analysis for remote monitoring in the cardiology field in Germany and the Netherlands
7. Working on the reimbursement analysis for local treatment of skin disorders in England and Germany

HEOR

1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
2. Working on the development of the reimbursement application for technology in the neurovascular field in Hungary 
3. Working on the literature review for assisted reproduction technology 
4. Working on the development of an early value dossier for wound treatment technology in European countries 
5. Initiating work on the development of an HTA submission dossier in the UAE
6. Initiating work on an update of the systematic literature review for minimally invasive neurological technology 
7. Initiating work on the adaptation of health economic model for minimally invasive neurological technology 

Let us know if you need any market access or HEOR support for your medical technology in Europe.